Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodore Abraham

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|May 16, 2023
The (Heart and) Soul of a Human Creation: Designing Echocardiography for the Big Data AgeRima Arnaout, Rebecca T Hahn, Judy W Hung, et al.
Circulation. Cardiovascular Genetics|December 25, 2009
Comprehensive desmosome mutation analysis in north americans with arrhythmogenic right ventricular dysplasia/cardiomyopathyA Dénise den Haan, Boon Yew Tan, Michelle N Zikusoka, et al.
Frontiers in Medicine|September 29, 2025
High rate of seroeligibility among <i>MYBPC3</i>-associated hypertrophic cardiomyopathy patients for TN-201, an adeno-associated virus serotype 9 <i>MYBPC3</i> gene therapyMilind Y Desai, Daniele Massera, Heng Wang, et al.
Journal of the American College of Cardiology|December 20, 2005
Cardiac resynchronization therapy: Part 1--issues before device implantationJeroen J Bax, Theodore Abraham, S Serge Barold, et al.
Journal of the American College of Cardiology|December 20, 2005
Cardiac resynchronization therapy: Part 2--issues during and after device implantation and unresolved questionsJeroen J Bax, Theodore Abraham, S Serge Barold, et al.
JACC. Heart Failure|February 5, 2025
Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy: Design, Rationale, and Baseline Characteristics of ODYSSEY-HCMMilind Y Desai, Steve E Nissen, Theodore Abraham, et al.
Journal of the American College of Cardiology|August 27, 2025
Echocardiographic Changes With Mavacamten in Nonobstructive Hypertrophic Cardiomyopathy: Exploratory Insights From the ODYSSEY-HCM TrialMilind Y Desai, Yuichiro Okushi, Shada Jadam, et al.
The New England Journal of Medicine|September 1, 2025
Mavacamten in Symptomatic Nonobstructive Hypertrophic CardiomyopathyMilind Y Desai, Anjali T Owens, Theodore Abraham, et al.
ESC Heart Failure|February 19, 2026
Efficacy of aficamten according to geographic location of patients with hypertrophic obstructive cardiomyopathyCaroline J Coats, Theodore Abraham, Roberto Barriales-Villa, et al.
European Heart Journal. Cardiovascular Imaging|January 30, 2026
Clinical Applications of Strain Echocardiography: A Clinical Consensus Statement From the American Society of Echocardiography Developed in Collaboration With the European Association of Cardiovascular Imaging of the European Society of CardiologyJames D Thomas, Thor Edvardsen, Theodore Abraham, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|May 16, 2023
The (Heart and) Soul of a Human Creation: Designing Echocardiography for the Big Data AgeRima Arnaout, Rebecca T Hahn, Judy W Hung, et al.
Circulation. Cardiovascular Genetics|December 25, 2009
Comprehensive desmosome mutation analysis in north americans with arrhythmogenic right ventricular dysplasia/cardiomyopathyA Dénise den Haan, Boon Yew Tan, Michelle N Zikusoka, et al.
Frontiers in Medicine|September 29, 2025
High rate of seroeligibility among <i>MYBPC3</i>-associated hypertrophic cardiomyopathy patients for TN-201, an adeno-associated virus serotype 9 <i>MYBPC3</i> gene therapyMilind Y Desai, Daniele Massera, Heng Wang, et al.
Journal of the American College of Cardiology|December 20, 2005
Cardiac resynchronization therapy: Part 1--issues before device implantationJeroen J Bax, Theodore Abraham, S Serge Barold, et al.
Journal of the American College of Cardiology|December 20, 2005
Cardiac resynchronization therapy: Part 2--issues during and after device implantation and unresolved questionsJeroen J Bax, Theodore Abraham, S Serge Barold, et al.
JACC. Heart Failure|February 5, 2025
Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy: Design, Rationale, and Baseline Characteristics of ODYSSEY-HCMMilind Y Desai, Steve E Nissen, Theodore Abraham, et al.
Journal of the American College of Cardiology|August 27, 2025
Echocardiographic Changes With Mavacamten in Nonobstructive Hypertrophic Cardiomyopathy: Exploratory Insights From the ODYSSEY-HCM TrialMilind Y Desai, Yuichiro Okushi, Shada Jadam, et al.
The New England Journal of Medicine|September 1, 2025
Mavacamten in Symptomatic Nonobstructive Hypertrophic CardiomyopathyMilind Y Desai, Anjali T Owens, Theodore Abraham, et al.
ESC Heart Failure|February 19, 2026
Efficacy of aficamten according to geographic location of patients with hypertrophic obstructive cardiomyopathyCaroline J Coats, Theodore Abraham, Roberto Barriales-Villa, et al.
European Heart Journal. Cardiovascular Imaging|January 30, 2026
Clinical Applications of Strain Echocardiography: A Clinical Consensus Statement From the American Society of Echocardiography Developed in Collaboration With the European Association of Cardiovascular Imaging of the European Society of CardiologyJames D Thomas, Thor Edvardsen, Theodore Abraham, et al.
Pageof 8